A Comprehensive 5K plus Glycan Microarray

Information

  • Research Project
  • 9407238
  • ApplicationId
    9407238
  • Core Project Number
    R43GM123820
  • Full Project Number
    1R43GM123820-01A1
  • Serial Number
    123820
  • FOA Number
    PA-16-157
  • Sub Project Id
  • Project Start Date
    8/1/2017 - 7 years ago
  • Project End Date
    7/31/2019 - 5 years ago
  • Program Officer Name
    MARINO, PAMELA
  • Budget Start Date
    8/1/2017 - 7 years ago
  • Budget End Date
    7/31/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    7/24/2017 - 7 years ago
Organizations

A Comprehensive 5K plus Glycan Microarray

Project Summary / Abstract There is growing need of high-throughput analytical platforms to study interactions of cell-surface glycans and glycan-binding proteins. We propose here to develop a 5K+ glycan array to facilitate functional glycomics research. Two hurdles for development of a comprehensive glycan array are (1) lack of a sensitive glycan array substrate enabling multivalent binding events, and (2) lack of a comprehensive glycan library of glycan structures representing the whole glycomes. To solve this challenge, Z Biotech will team with Chemily Glycoscience to deliver the most comprehensive glycan array and glycan sub-arrays to market. Z Biotech invented a robust microarray substrate having the advantage to display glycans on solid surface in multivalent form, and Chemily is a leading glycoscience company in production of complex glycans, sugar nucleotides and glycan-related enzymes. The proposed research strategy has been supported by a preliminary experimental investigation under collaboration between the two companies. In Phase I, our specific aims are (1) collection and synthesis of 1.2K+ glycans in 8 categories (sub-arrays), and (2) 1.2K+ glycan array manufacturing and QC/QA evaluation. Finally, the glycan arrays will be provided to large glycan array screening centers for further evaluation. These are realistic goals within a SBIR program frame and the resultant glycan array products will have a broad impact on glycobiology research, glycan-related biomarker characterization and new drug development.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    154935
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:154935\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    Z BIOTECH, LLC
  • Organization Department
  • Organization DUNS
    079149797
  • Organization City
    AURORA
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    800457337
  • Organization District
    UNITED STATES